Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Duration of Antihistamine Therapy for Chronic Allergic Rhinitis

Patterns of Allergic Rhinitis and Treatment Duration

  • For persistent allergic rhinitis, continuous antihistamine treatment is recommended rather than intermittent use, primarily because of unavoidable, ongoing allergen exposure, as suggested by the American Academy of Allergy, Asthma, and Immunology 1
  • For intermittent or episodic allergic rhinitis, antihistamines may be used on an as-needed basis due to their relatively rapid onset of action, according to the American College of Allergy, Asthma, and Immunology 2

Antihistamine Selection for Long-term Use

  • Second-generation antihistamines are preferred for chronic treatment of allergic rhinitis due to their favorable safety profile and minimal risk of sedation or performance impairment, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1

Treatment Algorithms Based on Symptom Severity

  • For mild persistent symptoms of allergic rhinitis, continuous treatment with second-generation antihistamines is recommended, as suggested by the American Academy of Allergy, Asthma, and Immunology 1 and the American Academy of Otolaryngology-Head and Neck Surgery 3
  • For patients with both allergic rhinitis and asthma, prolonged antihistamine therapy with agents like levocetirizine has been shown to reduce comorbidities and improve rhinitis-specific quality of life, according to the European Academy of Allergy and Clinical Immunology 4

Monitoring and Adjusting Long-term Therapy

  • Patients on long-term antihistamine therapy should be periodically reassessed for symptom control, medication adherence, side effects, and need for treatment adjustment, as recommended by the American College of Allergy, Asthma, and Immunology 5

Pitfalls and Caveats

  • Avoid continuous use of intranasal decongestants beyond 3-7 days due to risk of rhinitis medicamentosa, as warned by the American Academy of Allergy, Asthma, and Immunology 1
  • For patients with inadequate response to pharmacologic therapy, consider referral for immunotherapy rather than indefinite antihistamine use, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 3